Literature DB >> 1849679

Analysis of putative active site residues of the poliovirus 3C protease.

K M Kean1, N L Teterina, D Marc, M Girard.   

Abstract

It was recently suggested that the picornavirus 3C proteases are homologous to the chymotrypsin-like serine proteases. The two structural models proposed differ in one of the postulated active site residues, Glu/Asp71 or Asp85. We changed Glu71 of the poliovirus type 1 protease to Asp or Gln and Asp85 to Glu by oligonucleotide-directed site-specific mutagenesis of an infectious cDNA, and attempted to recover virus after transfection. Both Glu71 changes were lethal for the virus and proteolytic activity was abolished in vitro with the exception of the primary cleavage event at the P2/P3 junction. In contrast, the Asp85----Glu virus was viable. This mutant was temperature-sensitive for growth at 39 degrees and exhibited a minute plaque phenotype at permissive temperature. This defect correlated with low levels of viral-specific RNA and protein syntheses and slow virus growth. Proteolytic processing at the COOH-terminus of 3C was impaired, reducing the production of mature 3C and the viral replicase 3D. In addition, 3C-mediated cleavage events within the P2 region of the polyprotein seemed to occur rather inefficiently. 3C-specific processing within P1 and elsewhere within P3 was unaffected. We suggest that Asp85 does not form part of the active site of 3C, but could be important for the specific recognition of cleavage sites within P2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849679     DOI: 10.1016/0042-6822(91)90894-h

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Poliovirus thiol proteinase 3C can utilize a serine nucleophile within the putative catalytic triad.

Authors:  M A Lawson; B L Semler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 2.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

3.  In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.

Authors:  A K Patick; S L Binford; M A Brothers; R L Jackson; C E Ford; M D Diem; F Maldonado; P S Dragovich; R Zhou; T J Prins; S A Fuhrman; J W Meador; L S Zalman; D A Matthews; S T Worland
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Intracellular membrane proliferation in E. coli induced by foot-and-mouth disease virus 3A gene products.

Authors:  S Weber; H Granzow; F Weiland; O Marquardt
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

Review 5.  The picornaviral 3C proteinases: cysteine nucleophiles in serine proteinase folds.

Authors:  B A Malcolm
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

Review 6.  Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions.

Authors:  A G Porter
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus.

Authors:  B Boniotti; C Wirblich; M Sibilia; G Meyers; H J Thiel; C Rossi
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli.

Authors:  J C Alvey; E E Wyckoff; S F Yu; R Lloyd; E Ehrenfeld
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Mutational analysis of the proposed FG loop of poliovirus proteinase 3C identifies amino acids that are necessary for 3CD cleavage and might be determinants of a function distinct from proteolytic activity.

Authors:  T Hämmerle; A Molla; E Wimmer
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation.

Authors:  Kuo-Feng Weng; Mei-Ling Li; Chuan-Tien Hung; Shin-Ru Shih
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.